Benzinga | Jul 28, 2020 04:11PM EDT

Amedisys Q2 Adj. EPS $1.34 Beats $0.81 Estimate, Sales $485.00M Beat $469.13M Estimate

Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $0.81 by 65.43 percent. This is a 10.74 percent increase over earnings of $1.21 per share from the same period last year. The company reported quarterly sales of $485.00 million which beat the analyst consensus estimate of $469.13 million by 3.38 percent. This is a 1.62 percent decrease over sales of $492.98 million the same period last year.